Business strategy

Business strategy

Follicum’s main income is expected to come from out-licensing or sale of all or part of the company’s pharmaceutical projects to pharmaceutical companies and/or financial investors, after having entered into clinical development phases. Follicum does not intend to set up a sales organization for the sale of pharmaceutical products.

Read More: